Abstract
Purpose: Diamond–Blackfan anaemia (DBA) is a rare pure congenital red cell aplasia, usually presenting in infancy or early childhood. The literature suggests a predisposition to haemopoietic malignancy but in addition solid tumours have been reported, with five cases of osteosarcoma described.
Patient: A sixth case of a 12-year-old girl with DBA who developed an osteosarcoma of the distal femur is presented.
Results: She was treated with methotrexate followed by tumour excision and distal femoral replacement. The patient is currently alive with multiple pulmonary metastases.
Discussion: We discuss the association between the administration of growth hormone and future development of malignancy in patients with DBA.
Full Text
The Full Text of this article is available as a PDF (257.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aquino V. M., Buchanan G. R. Osteogenic sarcoma in a child with transfusion-dependent Diamond-Blackfan anemia. J Pediatr Hematol Oncol. 1996 May;18(2):230–232. doi: 10.1097/00043426-199605000-00030. [DOI] [PubMed] [Google Scholar]
- Braczkowski Ryszard, Schally Andrew V., Plonowski Artur, Varga Jozsef L., Groot Kate, Krupa Magdalena, Armatis Patricia. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Cancer. 2002 Oct 15;95(8):1735–1745. doi: 10.1002/cncr.10865. [DOI] [PubMed] [Google Scholar]
- Darendeliler Feyza, Bundak Rüveyde, Eryilmaz Sema Kabataş, Günöz Hülya, Baş Firdevs, Saka Nurçin. Follow-up height after discontinuation of growth hormone treatment in children with intrauterine growth retardation. J Pediatr Endocrinol Metab. 2002 Jun;15(6):795–800. doi: 10.1515/jpem.2002.15.6.795. [DOI] [PubMed] [Google Scholar]
- Hall M. B., Sclar A. G., Gardner D. F. Albright's syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Report of a case. Oral Surg Oral Med Oral Pathol. 1984 Jun;57(6):616–619. doi: 10.1016/0030-4220(84)90282-2. [DOI] [PubMed] [Google Scholar]
- Lipton J. M., Federman N., Khabbaze Y., Schwartz C. L., Hilliard L. M., Clark J. I., Vlachos A., Diamond-Black Anemia Registry Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. J Pediatr Hematol Oncol. 2001 Jan;23(1):39–44. doi: 10.1097/00043426-200101000-00009. [DOI] [PubMed] [Google Scholar]
- Pinski J., Schally A. V., Groot K., Halmos G., Szepeshazi K., Zarandi M., Armatis P. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst. 1995 Dec 6;87(23):1787–1794. doi: 10.1093/jnci/87.23.1787. [DOI] [PubMed] [Google Scholar]
- Scheven B. A., Hamilton N. J., Fakkeldij T. M., Duursma S. A. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. Growth Regul. 1991 Dec;1(4):160–167. [PubMed] [Google Scholar]
- Willig T. N., Niemeyer C. M., Leblanc T., Tiemann C., Robert A., Budde J., Lambiliotte A., Kohne E., Souillet G., Eber S. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res. 1999 Nov;46(5):553–561. doi: 10.1203/00006450-199911000-00011. [DOI] [PubMed] [Google Scholar]